RBC Boosts Price Target on Pyxis Oncology to $10 From $7, Keeps Outperform, Speculative Risk
RBC Boosts Price Target on Pyxis Oncology to $10 From $7, Keeps Outperform, Speculative Risk
RBC将Pyxis Oncology的目标价从7美元上调至10美元，维持跑赢大盘评级，属投机风险。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册
资讯热榜
更新时间